Form 8-K - Current report:
SEC Accession No. 0001100412-18-000021
Filing Date
2018-08-10
Accepted
2018-08-10 08:31:13
Documents
5
Period of Report
2018-08-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8102018_8-kxcarriexcox.htm 8-K 38390
2 EXHIBIT 99.1 a81018carriecox.htm EX-99.1 9576
3 a81018carriecox001.jpg GRAPHIC 241579
4 a81018carriecox002.jpg GRAPHIC 262418
5 a81020188kcarriecoximage1.jpg GRAPHIC 146580
  Complete submission text file 0001100412-18-000021.txt   945225
Mailing Address 3200 WALNUT STREET BOULDER CO 80301
Business Address 3200 WALNUT STREET BOULDER CO 80301 3033816600
ARRAY BIOPHARMA INC (Filer) CIK: 0001100412 (see all company filings)

IRS No.: 841460811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-16633 | Film No.: 181007083
SIC: 2834 Pharmaceutical Preparations